NVTA Insider Trading Activity and SEC Form 4 Filings
NVTA insider trading summary
No open-market insider purchases or sales of Invitae Corp (NVTA) have been reported on SEC Form 4 in the past 12 months.
Latest NVTA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 13, 2023 | Robert L Nussbaum | Chief Medical Officer | Sell | $10K (7,086 @ $1.38) |
| Jun 13, 2023 | Thomas Brida | See Remarks | Sell | $10K (7,079 @ $1.38) |
| May 16, 2023 | Thomas Brida | See Remarks | Sell | $32K (26,476 @ $1.20) |
| May 16, 2023 | Yafei Wen | Chief Financial Officer | Sell | $87K (43,452 @ $1.99) |
| May 16, 2023 | Robert F. Werner | Chief Accounting Officer | Sell | $26K (21,559 @ $1.20) |
| May 16, 2023 | Robert L Nussbaum | Chief Medical Officer | Sell | $32K (26,476 @ $1.20) |
| May 16, 2023 | Kenneth D. Knight | Chief Executive Officer | Sell | $54K (45,432 @ $1.20) |
| Mar 13, 2023 | Thomas Brida | See Remarks | Sell | $4K (2,625 @ $1.41) |
| Mar 13, 2023 | Yafei Wen | Chief Financial Officer | Sell | $4K (2,625 @ $1.41) |
| Mar 13, 2023 | Kenneth D. Knight | Chief Executive Officer | Sell | $3K (1,853 @ $1.41) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.